Our Treatments
JUMP TO
Put the power of a 24/7 tool in patients’ hands
Provide anytime, anywhere access to evidence-based approaches, like cognitive behavioral therapy, fluency training, and contingency management, with the clinically proven prescription digital therapeutic that meets their needs.1,2
Play Video
A 12-week clinical study showed that patients using reSET were more than 2x more likely to abstain from substance use than those who didn’t use reSET.2*
*During the last 4 weeks of trial.
For individuals with substance use disorder, reSET® is the first FDA-authorized prescription digital therapeutic that’s proven to increase abstinence and treatment retention.2,3 Patients prescribed reSET download it to their phone for secure, discreet, convenient access to therapy, interactive learning, and support. reSET lets them practice what you’ve taught them anytime, anywhere, and report daily triggers, cravings, and substance use—so they feel more engaged and supported between appointments, and you get a clearer picture of where they are in their recovery journey.2
reSET can help patients stay on their recovery journey*
*During 12 weeks of treatment.
Track patient cravings and triggers
Patients can record substance use, cravings, and triggers to make in-person or remote therapy more productive and meaningful.2
Get therapy on demand
Interactive cognitive behavioral therapy lessons help patients learn new skills they can use in everyday situations to support their recovery journey.2
Improve coping strategies
Questions at the end of each lesson help patients remember important ideas and practice skills to stay in treatment.2
Provide encouragement with rewards
Make use of reSET’s available contingency management capabilities to provide patients with tangible rewards, like accomplishment badges and gift cards, to reinforce positive, healthier behaviors.2
Rewards may be virtual (nonmonetary) or in the form of gift cards (possibly ranging in amounts different from those shown here) and are at the discretion of the prescriber.
Previous
Next
ABOUT reSET-O
*During 12 weeks of treatment. Those who didn’t add reSET-O received treatment as usual.
For individuals with opioid use disorder, reSET-O® is the only FDA-authorized prescription digital therapeutic that’s proven to help patients stay in treatment longer.1,4 It works in a way that meets patients where they already are, on their smartphones, so they can turn screen time into therapy time. Patients prescribed reSET-O download it to their phone for secure, discreet, and convenient access to therapy, interactive learning, and support.
Meet the opioid crisis head on with reSET-O
Track patient cravings and triggers
Patients can record substance use, cravings, and triggers to make in-person or remote therapy more productive and meaningful.1
Get buprenorphine reminders
Patients can set up daily reminders to take their medication.1
Get therapy on demand
Interactive cognitive behavioral therapy lessons help patients learn new skills they can use in everyday situations to support their recovery journey.1
Improve coping strategies
Questions at the end of each lesson help patients remember important ideas and practice skills to stay in treatment.1
Provide encouragement with rewards
Make use of reSET-O’s available contingency management capabilities to provide patients with tangible rewards, like accomplishment badges and gift cards, to reinforce positive, healthier behaviors.1
Rewards may be virtual (nonmonetary) or in the form of gift cards (possibly ranging in amounts different from those shown here) and are at the discretion of the prescriber.
Previous
Next
CLINICIAN DASHBOARD
Optimize treatment and enrich sessions using real-world patient data1,2
Clinician Dashboard
Using objective, measurable data, the Clinician Dashboard helps you gain deeper, big picture insight that can add up to a more complete view of patients and their treatment trajectory.Looking for the Clinician Dashboard log-in page? Current prescribers go here.
Core lessons
reSET and reSET-O give patients access to 12 weeks of core lessons in cognitive behavioral therapy.1,2 reSET-O includes lessons specific to opioid use disorder.1 Both prescription digital therapeutics allow you to follow patient progress throughout treatment.- Review which lessons your patient has completed and when1,2
- Reassign lessons as needed for more individualized treatment1,2
Looking for the Clinician Dashboard log-in page? Current prescribers go here.
Rewards
Provide encouragement with rewards that can help patients stay motivated on their recovery journey.1,2- Set up rewards for patients who successfully complete a lesson or a negative drug screen1,2
- Select the type of rewards you want them to receive, such as badges or gift cards1,2
- Turn off monetary rewards if you do not want to include them in your practice1,2
Looking for the Clinician Dashboard log-in page? Current prescribers go here.
Calendar
The calendar feature lets you access key information quickly and easily, so you can guide patient conversations and keep your practice running smoothly.- Store and organize appointment attendance and drug screen data1,2
- Quickly access compliance information before patient meetings1,2
- Find information easily thanks to the simple color-coded system1,2
Looking for the Clinician Dashboard log-in page? Current prescribers go here.
Cravings and triggers
As patients progress through the 12-week program, they’re encouraged to enter real-time data on cravings and triggers so you can track their progress with at-a-glance charting.- Review patient-reported data on substance use, cravings, and triggers1,2
- View ready-made data visualizations, such as charts and graphs1,2
- Identify patterns and better understand patient challenges to recovery1,2
Previous
Next
next steps
See the process
Hear from HCPs and patients as they talk about the ways reSET-O and reSET are helping them stay connected, accountable and fully engaged in recovery.
Prescribing and support.
The PearConnect™ Service Center is all about helping you and your patients stay focused on treatment and recovery. Start here for flexible prescribing options, downloadable forms, tech assistance and more.
Interested in prescribing reSET or reSET-O?
reSET® Indications for Use:
reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older, who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 day) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse.
It is intended to:
- increase abstinence from a patient’s substances of abuse during treatment, and
- increase retention in the outpatient treatment program.
reSET® Important Safety Information for Clinicians:
Warnings: reSET is intended for patients whose primary language is English with a reading level of 7th grade or above, and who have access to an Android/iOS tablet or smartphone. reSET is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).
Clinicians should not use reSET to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.
reSET is not intended to be used as a stand-alone therapy for substance use disorder (SUD). reSET does not replace care by a licensed medical practitioner and is not intended to reduce the amount of face-to-face clinician time. reSET does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider.
Patients with substance use disorder experience mental health disease and co-morbid medical problems at higher rates than the general population. Patients with substance use disorder also have higher baseline rates of suicidal ideation, and suicide attempts, and suicide completion. Clinicians should engage in their normal care practices to monitor patients for medical problems and mental health disorders, including risk for harming others and/or themselves.
The long-term benefit of treatment with reSET on abstinence has not been evaluated in studies lasting beyond 12 weeks (90 days) in the SUD population. The ability of reSET to prevent potential relapse after treatment discontinuation has not been studied.
The effectiveness of reSET has not been demonstrated in patients currently reporting opioids as their primary substance of abuse.
Please see the Clinician Brief Summary Instructions for reSET.
reSET-O® Indications for Use:
reSET-O prescription digital therapeutic is a 12-week (84 day) software application intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.
reSET-O® Important Safety Information for Patients:
Warnings/precautions: reSET-O is intended for patients whose primary language is English with a reading level of 7th grade or above, and who have access to an Android/iOS tablet or smartphone. reSET-O is intended only for patients who own a smartphone and are familiar with use of smartphone apps (applications).
Clinicians should not use reSET-O to communicate with their patients about emergency medical issues. Patients should be clearly instructed not to use reSET-O to communicate to their clinician any urgent or emergent information. In case of an emergency, patients should dial 911 or go to the nearest emergency room.
reSET-O is not intended to be used as a stand-alone therapy for Opioid Use Disorder (OUD). reSET-O does not replace care by a licensed medical practitioner and is not intended to reduce the frequency or duration of in-person therapy. reSET-O does not represent a substitution for a patient’s medication. Patients should continue to take their medications as directed by their healthcare provider.
Patients with opioid use disorder experience mental health disease and co-morbid medical problems at higher rates than the general population. Patients with opioid use disorder have higher baseline rates of suicidal ideation, and suicide attempts, and suicide completion. Clinicians should undertake standard of care to monitor patients for medical problems and mental health disease, including risk for harming others and/or themselves.
The long-term benefit of reSET-O has not been evaluated in studies lasting beyond 12 weeks (84 days) in the OUD population. The ability of reSET-O to prevent potential relapse after therapy discontinuation has not been studied.
Please see the Clinician Brief Summary Instructions for reSET-O.
References:
1. reSET-O Clinician directions for use. Pear Therapeutics, Inc. 2020.
2. reSET Clinician directions for use. Pear Therapeutics, Inc. 2020.
3. FDA permits marketing of mobile medical application for substance use disorder. News Release. Silver Spring, MD: US Food and Drug Administration. September 14, 2017. Accessed May 18, 2020. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-mobile-medical-application-substance-use-disorder
4. FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs. News release. Silver Spring, MD: US Food and Drug Administration. December 10, 2018. Accessed May 18, 2020. https://www.fda.gov/news-events/press-announcements/fda-clears-mobile-medical-app-help-those-opioid-use-disorder-stay-recovery-programs
